Salpingectomy may cut ovarian cancer risk. So why does it still sound experimental?

A July 2026 New York Times report describes opportunistic salpingectomy as a “new approach” to prevent ovarian cancer.^[] But the procedure itself is not new. 

Opportunistic salpingectomy involves removing both fallopian tubes while the patient is already undergoing another operation, usually hysterectomy, permanent contraception, or pelvic surgery, while preserving the ovaries.

Recent data

In 2026, a British Columbia cohort of 85,823 patients found a 78% lower risk of serous ovarian cancer after opportunistic bilateral salpingectomy than after hysterectomy alone or tubal ligation (HR, 0.22; 95% CI, 0.05-0.95).^[] 

The same week, a European Society of Gynaecological Oncology (ESGO) consensus developed from a review of 129 relevant studies urged clinicians to include the procedure in preoperative counseling.^[]

For these patients, risk-reducing salpingo-oophorectomy remains the established intervention after childbearing, generally at ages 35-40 for BRCA1 and 40-45 for BRCA2.^[]

Clinical considerations

The 2026 ESGO consensus statement says, “Opportunistic salpingectomy is significantly associated with a lower risk of subsequent tubo-ovarian carcinoma, with no adverse short-term impact on ovarian function.”^[] The report calls the procedure “safe” and adds, “Existing evidence does not indicate harm to ovarian function or premature menopause, although long-term evidence is not available. Salpingectomy is feasible during both gynecological and nongynecological procedures and should be considered in women undergoing gynecological surgery and, where possible, in women undergoing selected nongynecological pelvic or abdominal surgeries.”

In her opinion, gynecologist Himali Maniar Patel, MD, says, “Opportunistic salpingectomy is a highly efficient addition that does not significantly increase patient risk under anesthesia.”

In the r/medicine on Reddit, one anonymous commenter wrote, “This is the standard method of elective female sterilization where I practice (as opposed to tubal ligation).” Another self-described clinician said salpingectomy had replaced ligation in most cases.^[] 

Discussing the safety considerations of the procedure, Dr. Patel explains, “The use of modern vessel-sealing devices and advanced bipolar electrosurgery allows for the rapid and secure removal of the fallopian tubes without disrupting the primary surgical flow.”

Operative challenges 

Despite the benefits of the procedure, Dr. Patel warns, “The procedure should never be forced if anatomy is compromised. Severe pelvic adhesions from prior abdominal surgeries, extensive endometriosis, or distorted pelvic anatomy (such as large fibroids obscuring the adnexa) make complete bilateral removal difficult and potentially unsafe.”

Patient perceptions

Dr. Patel knows that patients are often concerned about the impact of this procedure on ovarian reserve and menopause risk. “Patients frequently express concern about how removing the tubes will affect their hormones,” she says. However, there is some reassurance. “Current clinical evidence,” she says, “heavily supports that short-term ovarian reserve, typically measured by anti-Mullerian hormone (AMH) levels, remains unchanged following a meticulously performed opportunistic salpingectomy.”